These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 6832206)
1. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study. Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses. Schuppan D; Molz KH; Staib AH; Rietbrock N Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238 [TBL] [Abstract][Full Text] [Related]
3. Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit. II. Multiple dose study. Ishizaki T; Horai Y; Sasaki T; Chiba K; Ohnishi A; Suganuma T; Tsujimoto G; Echizen H; Okaniwa T Eur J Clin Pharmacol; 1983; 24(3):361-9. PubMed ID: 6861849 [No Abstract] [Full Text] [Related]
4. [Bioavailability of a delayed-action aminophylline preparation]. Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030 [TBL] [Abstract][Full Text] [Related]
5. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults. Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a sustained-release theophylline preparation in healthy subjects. Goto M; Nakamoto Y; Sugiyama M; Yamashina H J Pharmacobiodyn; 1983 Apr; 6(4):225-31. PubMed ID: 6620110 [TBL] [Abstract][Full Text] [Related]
7. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels. Steinijans VW; Zech K; Fischer R Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100 [TBL] [Abstract][Full Text] [Related]
8. A multiple-dose study of sustained-release theophylline and aminophylline. Meyer MC; Straughn AB; Lieberman P Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417 [TBL] [Abstract][Full Text] [Related]
9. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing. Schulz HU; Steinijans VW; Gabel H Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759 [TBL] [Abstract][Full Text] [Related]
10. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I. Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse. Goetz TE; Munsiff IJ; McKiernan BC J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856 [TBL] [Abstract][Full Text] [Related]
12. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II. Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632 [TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of theophylline and ethylenediamine following single and repeated doses of a sustained-release aminophylline preparation to volunteers. Cotgreave IA; Caldwell J J Pharm Pharmacol; 1985 Sep; 37(9):618-21. PubMed ID: 2867181 [TBL] [Abstract][Full Text] [Related]
14. Absorption of theophylline from conventional and sustained-release tablets. Fagerström PO; Mellstrand T; Svedmyr N Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs. Bach JE; Kukanich B; Papich MG; McKiernan BC J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of theophylline and aminophylline in man. Aslaksen A; Bakke OM; Vigander T Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528 [TBL] [Abstract][Full Text] [Related]
17. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets. Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770 [TBL] [Abstract][Full Text] [Related]
18. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions. Steinijans VW; Schulz HU; Böhm A; Beier W Eur J Clin Pharmacol; 1987; 33(5):523-6. PubMed ID: 3428347 [TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets. Sansom LN; Milne RW; Cooper D Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]